N M van Schoor1, E Dennison2, M V Castell3, C Cooper2, M H Edwards2, S Maggi4, N L Pedersen5, S van der Pas6, J J M Rijnhart7, P Lips8, D J H Deeg7. 1. Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health, Amsterdam, the Netherlands. Electronic address: nm.vanschoor@amsterdamumc.nl. 2. University of Southampton, Southampton General Hospital, Southampton, United Kingdom. 3. Doctor Castroviejo Health Center, Northern Health Care Directorate of the Community of Madrid, Medicine Department, Family Medicine and Primary Care Division, School of Medicine, Autonoma University of Madrid, Hospital La Paz Institute for Health Research (IdiPAZ) Madrid, Spain. 4. National Research Council, Neuroscience Institute, Padua, Italy. 5. Karolinska Institutet, Stockholm, Sweden. 6. Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health, Amsterdam, the Netherlands; University of Applied Sciences Leiden, Leiden, the Netherlands. 7. Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health, Amsterdam, the Netherlands. 8. Department of Internal Medicine, Endocrine Section, VU University Medical Center, Amsterdam, the Netherlands.
Abstract
OBJECTIVE: Several studies have found an increased fall risk in persons with osteoarthritis (OA). However, most prospective studies did not use a clinical definition of OA. In addition, it is not clear which factors explain this risk. Our objectives were: (1) to confirm the prospective association between clinical OA of the hip and knee and falls; (2) to examine the modifying effect of sex; and (3) to examine whether low physical performance, low physical activity and use of pain medication are mediating these relationships. METHODS: Baseline and 1-year follow-up data from the European Project on OSteoArthritis (EPOSA) were used involving pre-harmonized data from five European population-based cohort studies (ages 65-85, n = 2535). Clinical OA was defined according to American College of Rheumatology (ACR) criteria. Falls were assessed using self-report. RESULTS: Over the follow-up period, 27.7% of the participants fell once or more (defined as faller), and 9.8% fell twice or more (recurrent faller). After adjustment for confounding, clinical knee OA was associated with the risk of becoming a recurrent faller (relative risk=1.55; 95% confidence interval: 1.10-2.18), but not with the risk of becoming a faller. No associations between clinical hip OA and (recurrent) falls were observed after adjustment for confounding. Use of opioids and analgesics mediated the associations between clinical OA and (recurrent) falls, while physical performance and physical activity did not. CONCLUSION: Individuals with clinical knee OA were at increased risk for recurrent falls. This relationship was mediated by pain medication, particularly opioids. The fall risk needs to be considered when discussing the risk benefit ratio of prescribing these medications.
OBJECTIVE: Several studies have found an increased fall risk in persons with osteoarthritis (OA). However, most prospective studies did not use a clinical definition of OA. In addition, it is not clear which factors explain this risk. Our objectives were: (1) to confirm the prospective association between clinical OA of the hip and knee and falls; (2) to examine the modifying effect of sex; and (3) to examine whether low physical performance, low physical activity and use of pain medication are mediating these relationships. METHODS: Baseline and 1-year follow-up data from the European Project on OSteoArthritis (EPOSA) were used involving pre-harmonized data from five European population-based cohort studies (ages 65-85, n = 2535). Clinical OA was defined according to American College of Rheumatology (ACR) criteria. Falls were assessed using self-report. RESULTS: Over the follow-up period, 27.7% of the participants fell once or more (defined as faller), and 9.8% fell twice or more (recurrent faller). After adjustment for confounding, clinical knee OA was associated with the risk of becoming a recurrent faller (relative risk=1.55; 95% confidence interval: 1.10-2.18), but not with the risk of becoming a faller. No associations between clinical hipOA and (recurrent) falls were observed after adjustment for confounding. Use of opioids and analgesics mediated the associations between clinical OA and (recurrent) falls, while physical performance and physical activity did not. CONCLUSION: Individuals with clinical knee OA were at increased risk for recurrent falls. This relationship was mediated by pain medication, particularly opioids. The fall risk needs to be considered when discussing the risk benefit ratio of prescribing these medications.
Authors: Adam L Doré; Yvonne M Golightly; Vicki S Mercer; Xiaoyan A Shi; Jordan B Renner; Joanne M Jordan; Amanda E Nelson Journal: Arthritis Care Res (Hoboken) Date: 2015-05 Impact factor: 4.794
Authors: Marlene Fransen; Sara McConnell; Alison R Harmer; Martin Van der Esch; Milena Simic; Kim L Bennell Journal: Cochrane Database Syst Rev Date: 2015-01-09
Authors: Lotta J Seppala; Esther M M van de Glind; Joost G Daams; Kimberley J Ploegmakers; Max de Vries; Anne M A T Wermelink; Nathalie van der Velde Journal: J Am Med Dir Assoc Date: 2018-03-02 Impact factor: 4.669
Authors: Florian Herbolsheimer; Laura A Schaap; Mark H Edwards; Stefania Maggi; Ángel Otero; Erik J Timmermans; Michael D Denkinger; Suzan van der Pas; Joost Dekker; Cyrus Cooper; Elaine M Dennison; Natasja M van Schoor; Richard Peter Journal: Arthritis Care Res (Hoboken) Date: 2016-02 Impact factor: 4.794
Authors: Vianda S Stel; Johannes H Smit; Saskia M F Pluijm; Marjolein Visser; Dorly J H Deeg; Paul Lips Journal: J Clin Epidemiol Date: 2004-03 Impact factor: 6.437
Authors: Daniel Prieto-Alhambra; Xavier Nogues; M Kassim Javaid; Allison Wyman; Nigel K Arden; Rafael Azagra; Cyrus Cooper; Jonathan D Adachi; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Stephen H Gehlbach; Susan L Greenspan; Frederick H Hooven; J Coen Netelenbos; Johannes Pfeilschifter; Maurizio Rossini; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Adolfo Díez-Pérez Journal: Ann Rheum Dis Date: 2012-06-23 Impact factor: 19.103
Authors: N M van Schoor; S Zambon; M V Castell; C Cooper; M Denkinger; E M Dennison; M H Edwards; F Herbolsheimer; S Maggi; M Sánchez-Martinez; N L Pedersen; R Peter; L A Schaap; J J M Rijnhart; S van der Pas; D J H Deeg Journal: Qual Life Res Date: 2015-11-07 Impact factor: 4.147
Authors: Carla Guerreiro; Marta Botelho; Elia Fernández-Martínez; Ana Marreiros; Sandra Pais Journal: Int J Environ Res Public Health Date: 2022-02-16 Impact factor: 3.390
Authors: Catherine Park; Md Moin Uddin Atique; Ramkinker Mishra; Bijan Najafi Journal: Int J Environ Res Public Health Date: 2022-08-30 Impact factor: 4.614